Implanted pump improves chemotherapy survival rates
This article was originally published in Clinica
Patients with implanted chemotherapy pumps show significantly increased survival rates over those receiving traditional chemotherapy after surgery for metastatic liver cancer, according to two US studies. As a result, the pump should be used as the standard treatment for liver metastases from colorectal cancer, Dr Elin Sigurdson of Fox Chase Cancer Center told oncologists this week at the Society of Surgical Oncology's annual cancer symposium in New Orleans, Louisiana.
You may also be interested in...
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.